MAPK3 and cancer: Other studies have demonstrated that ERK‐triggered high DRP1S616 phosphorylation can activate autophagy through the RAGE/ERK1/2 pathway, resulting in chemoresistance and cancer cell regeneration [40] (Fig. 2A).